Revenue: The sum of all revenue fields included for a company's operating activities.
ALX Oncology Holdings Inc. (ALXO) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-30.75M |
|
-- |
|
-- |
|
$31.82M |
|
$-31.82M |
|
$1.07M |
|
$-30.75M |
|
$-30.75M |
|
$-30.75M |
|
$-30.75M |
|
$-30.75M |
|
$-30.75M |
|
$-31.82M |
|
$-32.07M |
|
53.36M |
|
53.36M |
|
$-0.58 |
|
$-0.58 |
|
| Balance Sheet Financials | |
$102.53M |
|
$2.70M |
|
$18.37M |
|
$120.90M |
|
$18.74M |
|
$8.23M |
|
$13.86M |
|
$32.60M |
|
$88.30M |
|
$88.30M |
|
$88.30M |
|
53.38M |
|
| Cash Flow Statement Financials | |
$-24.66M |
|
$27.64M |
|
$0.07M |
|
$17.63M |
|
$20.68M |
|
$3.05M |
|
$5.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.47 |
|
-- |
|
-- |
|
0.09 |
|
0.11 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-24.72M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-34.83% |
|
-34.83% |
|
-25.44% |
|
-31.86% |
|
$1.65 |
|
$-0.46 |
|
$-0.46 |
|